Tandem Diabetes Care Inc (NASDAQ: TNDM) kicked off on Monday, up 6.61% from the previous trading day, before settling in for the closing price of $30.11. Over the past 52 weeks, TNDM has traded in a range of $21.85-$53.69.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
A company in the Healthcare sector has jumped its sales by 36.59% annually for the last half of the decade. While this was happening, its average annual earnings per share was recorded 50.66%. With a float of $65.20 million, this company’s outstanding shares have now reached $65.65 million.
In an organization with 2400 employees, it is important to assess its efficiency. In terms of profitability, gross margin is 43.69%, operating margin of -13.72%, and the pretax margin is -12.65%.
Tandem Diabetes Care Inc (TNDM) Insider Updates
Our next focus will be how large-scale investors are participating in this stock of the Medical Devices Industry. The insider ownership of Tandem Diabetes Care Inc is 0.72%, while institutional ownership is 112.78%. The most recent insider transaction that took place on Nov 21 ’24, was worth 941,400. In this transaction Director of this company sold 30,000 shares at a rate of $31.38, taking the stock ownership to the 165,190 shares. Before that another transaction happened on Nov 20 ’24, when Company’s Director sold 10,000 for $30.00, making the entire transaction worth $300,000. This insider now owns 195,190 shares in total.
Tandem Diabetes Care Inc (TNDM) Performance Highlights and Predictions
According to the Wall Street analysts, stocks earnings will be around 50.66% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 38.80% during the next five years compared to -6.11% drop over the previous five years of trading.
Tandem Diabetes Care Inc (NASDAQ: TNDM) Trading Performance Indicators
Take a look at Tandem Diabetes Care Inc’s (TNDM) current performance indicators. Last quarter, stock had a quick ratio of 2.32. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 2.45.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.94, a number that is poised to hit -0.21 in the next quarter and is forecasted to reach -1.21 in one year’s time.
Technical Analysis of Tandem Diabetes Care Inc (TNDM)
Let’s dig in a bit further. During the last 5-days, its volume was 1.21 million. That was inferior than the volume of 1.59 million it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 28.53%. Additionally, its Average True Range was 1.86.
During the past 100 days, Tandem Diabetes Care Inc’s (TNDM) raw stochastic average was set at 24.21%, which indicates a significant decrease from 75.20% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 63.37% in the past 14 days, which was lower than the 65.37% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $33.62, while its 200-day Moving Average is $38.50. However, in the short run, Tandem Diabetes Care Inc’s stock first resistance to watch stands at $33.14. Second resistance stands at $34.19. The third major resistance level sits at $35.37. If the price goes on to break the first support level at $30.91, it is likely to go to the next support level at $29.73. Assuming the price breaks the second support level, the third support level stands at $28.68.
Tandem Diabetes Care Inc (NASDAQ: TNDM) Key Stats
The company with the Market Capitalisation of 2.10 billion has total of 65,677K Shares Outstanding. Its annual sales at the moment are 747,720 K in contrast with the sum of -222,610 K annual income. Company’s last quarter sales were recorded 243,970 K and last quarter income was -23,250 K.
